Navigation Links
American Airlines Applauded for Its Fundraising to Support Susan G. Komen for the Cure(R), Promise Grant to The University of Texas M. D. Anderson Cancer Center
Date:4/14/2009

Collaboration to Fight Inflammatory Breast Cancer Already Making Gains in First Year of Funding

DALLAS, April 14 /PRNewswire/ -- The University of Texas M. D. Anderson Cancer Center and Susan G. Komen for the Cure(R) today lauded thousands of American Airlines AAdvantage(R) members, employees, and Celebrity Golf and Tennis supporters for helping American meet its promise to fund the fight against a rare and aggressive form of breast cancer.

American's annual Celebrity Golf and Tennis event, plus its Miles for the Cure(TM) program - soon to launch its second year - are funding a unique Komen for the Cure Promise Grant at The University of Texas M. D. Anderson Cancer Center for new treatments for inflammatory breast cancer (IBC). The airline has pledged $8 million over eight years to fund a $7.5 million Promise Grant at M. D. Anderson's Morgan Welch Inflammatory Breast Cancer Clinic, the only clinic of its kind devoted to IBC.

In just one year, American Airlines raised more than $1 million toward that funding goal. Miles for the Cure, for which members of American's AAdvantage travel rewards program receive miles when they donate to Komen, will soon enter its second year. Celebrity Golf and Tennis will mark its 15th year in 2009.

"The real heroes in this effort are our customers and sponsors as well as our employees, whose generosity and support have made it possible to not only meet, but exceed our fundraising goal for Komen to date," said Roger Frizzell, American's vice president - corporate communications and advertising. "We have many loyal sponsors and employee volunteers who return each year to make Celebrity Golf and Tennis a resounding success, and nearly 11,000 AAdvantage members contributed to Miles for the Cure in 2008."

American, whose partnership with Susan G. Komen for the Cure began more than 20 years ago, was the first of Komen's corporate
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. While the Majority of Americans Express Interest in Organ and Tissue Donation, Too Few Take Steps to Register as Donors
2. American Biotech Labs(R) Obtains FDA Approval for New Wound Care Gel Product
3. American Legacy Foundation(R) and Georgetown University Medical Center Create Research Collaboration
4. The American Federation for Medical Research Unites Top Leaders to Mitigate U.S. Crisis in Clinical Research
5. While majority of Americans express interest in organ and tissue donation, few register
6. Thousands of Americans Sign Living Wills on Thursday April 16
7. Blue Cross and Blue Shield of Minnesota and American Well(TM) Join to Bring Online Care to Minnesota
8. New Low-Cost Handheld Device offers Independence for Millions of Visually Impaired Americans
9. American College of Pediatricians: Another Blow to Childrens Rights
10. Humanitas Approved by American Psychological Association (APA) as Provider of Continuing Education Credits to Psychologists
11. Wiley-Blackwell and the American Heart Association present new book series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and ... will expedite the delivery of laboratory samples and ... districts of the Northern and Central Zones of ... for Health will establish a dependable and coordinated ... critical bottleneck in health services for the more ...
(Date:7/31/2014)... View, Calif. and Las Vegas, Nevada (PRWEB) July 31, ... partnership with LaunchKey to provide next generation authentication services ... simple and secure way to utilize hardware protected multi-factor ... enormous problem in the Internet's reliance on password-based authentication. ... hacks and global data breaches taking place around the ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... to reach USD 37.83 billion by 2020, according ... Inc. Increasing geriatric population base augmenting the susceptibility ... orthopedic, and respiratory diseases coupled with increasing patient ... over the next six years. Some of the ...
(Date:7/31/2014)... 31, 2014 (HealthDay News) -- Recovery time after surgery ... known as statins, according to a new study. ... affect the body,s inflammatory response, reducing the amount of ... seemed to be particularly true among people who tend ... of the most widely prescribed medications in the world. ...
(Date:7/31/2014)... 2014 A new catheter being ... helping patients who have an abnormal heart rhythm. ... ablation procedures for patients such as those suffering ... Baptist Heart Specialists were the first in north ... past spring, according to Biosense Webster, which develops ...
Breaking Medicine News(10 mins):Health News:Elizabeth Glaser Pediatric AIDS Foundation partners with Riders for Health in Malawi 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 2Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 4Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 5Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 6Health News:Cholesterol Drugs May Speed Healing After Surgery 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 3
... near the World Trade Center had sleeplessness, other problems, ... Direct exposure to the World Trade Center terrorist ... , The study, by researchers at the Mount Sinai ... children averaging about 4 years of age who lived ...
... Merrill Lynch,s Global Pharmaceutical Conference Feb. ... 5, 2008, ... it will host a conference call and live webcast on,Wednesday, Feb. 27, 2008, ... ended Dec. 31, 2007. The Company also will provide,an operational and integration update ...
... CLARA, Calif., Feb. 5 Coherent, Inc.,(Pink Sheets: COHR), ... included in the company,s proxy for the annual meeting ... subject to election by,shareholders. The nominees include current directors ... Vij as well as first-time,nominees Susan James and Clifford ...
... Engineering,Group Inc. (NYSE: JEC ) announced today that ... in managing the Sequoia Hospital Program,in Redwood City, Calif. ... including a new 104-bed tower, a retrofit of 63 ... a parking structure. The,overall project is expected to be ...
... VIEW, Calif., Feb. 5 MAP,Pharmaceuticals, Inc. (Nasdaq: ... B. Shrewsbury, M.B., Ch.B., Chief Medical,Officer, will be leaving ... Shrewsbury plans to provide consulting services to the company,for ... want to thank Steve for his many contributions and ...
... Feb. 5 Favrille, Inc. (Nasdaq:,FVRL), a biopharmaceutical ... cancer, announced today that it will,host a conference ... Time on,Tuesday, February 19, 2008 to discuss the ... A press release will be issued before the ...
Cached Medicine News:Health News:9/11 Exposure Linked to Behavior Trouble in Kids 2Health News:Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007 2Health News:Coherent Announces Director Slate for Upcoming Annual Meeting 2Health News:Jacobs Receives Contract from Catholic Healthcare West to Assist Sequoia Hospital Expansion Program 2Health News:MAP Pharmaceuticals Announces Resignation of Chief Medical Officer 2Health News:Favrille to Host Conference Call and Live Webcast to Discuss Fourth Quarter and Year End 2007 Financial Results on February 19, 2008 2
(Date:7/31/2014)... , July 31, 2014 Astellas ... head of corporate and employee communications in the ... Jeff Winton , senior vice president, chief communications ... for developing and leading corporate brand initiatives and ... across North and South America ...
(Date:7/31/2014)... -- Cryoport, Inc. (OTCBB: CYRX) today announced financial results ... Recent Operating Highlights , Achieved ... month period ended June 30, 2014 compared to the ... further expand Cryoport,s global reach using the ,powered by ... Immudex, an immunotherapy and vaccine development services company, to ...
(Date:7/31/2014)... 2014 Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" ... premium branded consumer products, including commercially cultivated Cordyceps Militaris ... announced the signing of its first distributor for its ... Hubei Province located ... . The contract with the ...
Breaking Medicine Technology:Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4
... Confirm Robust Efficacy of CIMZIA, BOSTON, Nov. ... new,Phase III data from the RAPID 1 and ... Annual Scientific Meeting (ACR), which show,CIMZIA(R) (certolizumab pegol), ... Factor), given with methotrexate, is significantly,more effective than ...
... Fla., Nov. 7 A new analysis,presented today ... Evaluation Of Rosuvastatin) showed CRESTOR(R) (rosuvastatin calcium) 40,mg ... in four,patient populations at varying levels of risk ... subjects defined by the Framingham risk,assessment tool as ...
Cached Medicine Technology:CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 2CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 3CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 4CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 5CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 6CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 7CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 8New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 2New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 3New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 4New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 5New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 6
PremierEdge Stab Knives - 30....
... for the total eye. Whether used ... mode or set independently to accommodate ... settings are adjustable to accommodate maximizing ... for use with tonometer-mounted, hand-held and ...
PremierEdge™ MVR Knives. Angled....
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Medicine Products: